Innovation in QT Strategies: Leveraging Early-stage Safety Methodologies and AI to Maximize Your Opportunity for a TQT Waiver, Upcoming Webinar Hosted by Xtalks
Summary
Artificial intelligence (AI) is an ideal solution for these analyses to automatically screen continuous ECG recordings for a quality assessment without the need for human engagement. Register for this webinar to discover how precise cardiac safety data can reduce the need for costly TQT trials, enhance operational efficiency and provide critical insights to mitigate risks and improve success rates. Join Dr. Todd Rudo (moderator), MD, Executive Vice President, Chief Medical Officer, Clario; Dr. Vic Patel, MD, PhD, Vice President & Chief Medical Officer, Cardiology, Clario; and Dr. Jean-Philippe Couderc, PhD, MBA, Professor of Medicine and Computer/Electrical Engineering, University of Rochester, for the live webinar on Tuesday, January 21, 2025, at 11am EST (4pm GMT/UK). For more information, or to register for this event, visit Innovation in QT Strategies: Leveraging Early-stage Safety Methodologies and AI to Maximize Your Opportunity for a TQT Waiver. Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities.